European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community list of not active medicinal products for human use |
WITHDRAWN |
Product information |
| Invented name: | Ecokinase |
| Auth. number : | EU/1/96/017 |
| INN : | Reteplase |
| ATC: | B - Blood and blood forming organs B01 - Antithrombotic agents B01A - Antithrombotic agents B01AD - Enzymes B01AD07 - Reteplase (See WHO ATC Index) |
| Indication: | Thrombolytic therapy of acute myocardial infarction (AMI) (within 12 hours after the onset of AMI symptoms) |
| Marketing Authorisation Holder: | Galenus Mannheim GmbH
Sandhofer Straße 116, D-68298 Mannheim, Deutschland |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 30/08/1996 | Centralised - Authorisation | EMEA/H/C/106 | (96)2453 of 29/08/1996 | |||
| 05/08/1999 | Centralised - Withdrawal | - | (1999)2569 of 30/07/1999 |